BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25277271)

  • 21. Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men.
    Zheng SL; Hsing AW; Sun J; Chu LW; Yu K; Li G; Gao Z; Kim ST; Isaacs WB; Shen MC; Gao YT; Hoover RN; Xu J
    Prostate; 2010 Mar; 70(4):425-32. PubMed ID: 19866473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
    Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
    J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
    Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
    J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
    Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindström S; Albanes D; Ziegler RG; McCullough ML; Siddiq A; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Crawford ED; Diver WR; Gapstur SM; Giovannucci E; Gu F; Haiman CA; Hayes RB; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Overvad K; Polidoro S; Riboli E; Schumacher FR; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Key TJ
    Int J Cancer; 2013 Jul; 133(2):495-504. PubMed ID: 23341348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropy in aggressive prostate cancer?
    Cox A
    Eur Urol; 2015 Apr; 67(4):658-9. PubMed ID: 25468285
    [No Abstract]   [Full Text] [Related]  

  • 27. New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
    Nam RK; Zhang W; Siminovitch K; Shlien A; Kattan MW; Klotz LH; Trachtenberg J; Lu Y; Zhang J; Yu C; Toi A; Loblaw DA; Venkateswaran V; Stanimirovic A; Sugar L; Malkin D; Seth A; Narod SA
    Cancer Biol Ther; 2011 Dec; 12(11):997-1004. PubMed ID: 22130093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replication and meta-analysis of previous genome-wide association studies confirm vezatin as the locus with the strongest evidence for association with endometriosis.
    Pagliardini L; Gentilini D; Sanchez AM; Candiani M; Viganò P; Di Blasio AM
    Hum Reprod; 2015 Apr; 30(4):987-93. PubMed ID: 25678572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
    Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
    J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.
    Mocellin S; Tropea S; Benna C; Rossi CR
    BMC Med; 2018 Feb; 16(1):20. PubMed ID: 29455641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3).
    Mondul AM; Shui IM; Yu K; Weinstein SJ; Tsilidis KK; Joshi AD; Agudo A; Berg CD; Black A; Buring JE; Chasman DI; Gaudet MM; Haiman C; Hankinson SE; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kühn T; Kvaskoff M; Le Marchand L; Lindström S; McCullough ML; Overvad K; Peeters PH; Riboli E; Ridker PM; Stram DO; Sund M; Trichopoulos D; Tumino R; Weiderpass E; Willett W; Kraft P; Ziegler RG; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):627-30. PubMed ID: 25542828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.
    Tao S; Wang Z; Feng J; Hsu FC; Jin G; Kim ST; Zhang Z; Gronberg H; Zheng LS; Isaacs WB; Xu J; Sun J
    Carcinogenesis; 2012 Mar; 33(3):598-603. PubMed ID: 22219177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
    Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
    Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
    Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
    J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
    Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population.
    Liu M; Suzuki M; Arai T; Sawabe M; Enomoto Y; Nishimatsu H; Kume H; Homma Y; Kitamura T
    Prostate; 2011 Jul; 71(10):1023-32. PubMed ID: 21557267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
    Teerlink CC; Leongamornlert D; Dadaev T; Thomas A; Farnham J; Stephenson RA; Riska S; McDonnell SK; Schaid DJ; Catalona WJ; Zheng SL; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Giles GG; Southey MC; Fitzgerald LM; Rinckleb A; Luedeke M; Maier C; Stanford JL; Ostrander EA; Kaikkonen EM; Sipeky C; Tammela T; Schleutker J; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cancel-Tassin G; Cussenot O; Mandal D; Laurie C; Laurie C; ; ; Thibodeau SN; Eeles RA; Kote-Jarai Z; Cannon-Albright L
    Hum Genet; 2016 Aug; 135(8):923-38. PubMed ID: 27262462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.
    Knipe DW; Evans DM; Kemp JP; Eeles R; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Donovan JL; Hamdy FC; Neal DE; Smith GD; Lathrop M; Martin RM
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1356-1365. PubMed ID: 24753544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.